HEADER TRANSFERASE 20-AUG-09 2WQE TITLE STRUCTURE OF S155R AURORA-A SOMATIC MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 127-388; COMPND 5 SYNONYM: AURORA KINASE A, SERINE/THREONINE KINASE 15, COMPND 6 AURORA/IPL1-RELATED KINASE 1, BREAST TUMOR-AMPLIFIED COMPND 7 KINASE, AURORA-A, AURORA-RELATED KINASE 1, HARK1; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS POLYMORPHISM, PHOSPHOPROTEIN, NUCLEOTIDE-BINDING, CELL KEYWDS 2 CYCLE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.BIBBY,R.BAYLISS REVDAT 3 08-DEC-09 2WQE 1 JRNL REVDAT 2 13-OCT-09 2WQE 1 JRNL REVDAT 1 29-SEP-09 2WQE 0 JRNL AUTH R.A.BIBBY,C.TANG,A.FAISAL,K.DROSOPOULOS,S.LUBBE, JRNL AUTH 2 R.HOULSTON,R.BAYLISS,S.LINARDOPOULOS JRNL TITL A CANCER ASSOCIATED AURORA-A MUTANT IS JRNL TITL 2 MISLOCALISED AND MISREGULATED DUE TO LOSS OF JRNL TITL 3 INTERACTION WITH TPX2. JRNL REF J.BIOL.CHEM. V. 284 33177 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19801554 JRNL DOI 10.1074/JBC.M109.032722 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.500 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.249 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.07 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.16 REMARK 3 NUMBER OF REFLECTIONS : 10448 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.2062 REMARK 3 R VALUE (WORKING SET) : 0.2040 REMARK 3 FREE R VALUE : 0.2506 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.8 REMARK 3 FREE R VALUE TEST SET COUNT : 498 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.2578 - 3.9680 0.99 2669 138 0.1801 0.1990 REMARK 3 2 3.9680 - 3.1497 0.95 2417 117 0.1996 0.2577 REMARK 3 3 3.1497 - 2.7516 0.98 2471 128 0.2327 0.3230 REMARK 3 4 2.7516 - 2.5001 0.96 2393 115 0.2437 0.3258 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.363 REMARK 3 B_SOL : 38.898 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.34 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.7762 REMARK 3 B22 (A**2) : -0.7762 REMARK 3 B33 (A**2) : 6.8110 REMARK 3 B12 (A**2) : -0.0000 REMARK 3 B13 (A**2) : 0.0000 REMARK 3 B23 (A**2) : -0.0000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2049 REMARK 3 ANGLE : 1.243 2793 REMARK 3 CHIRALITY : 0.070 309 REMARK 3 PLANARITY : 0.004 341 REMARK 3 DIHEDRAL : 20.334 743 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WQE COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-09 REMARK 100 THE PDBE ID CODE IS EBI-40727 REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 92 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10725 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.50 REMARK 200 RESOLUTION RANGE LOW (A) : 85.40 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 7.5 REMARK 200 R MERGE (I) : 0.07 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.5 REMARK 200 R MERGE FOR SHELL (I) : 0.43 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OL6 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% (W/V) PEG3350, 15% (V/V) REMARK 280 GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.97450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 42.78750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 42.78750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.98725 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 42.78750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 42.78750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 59.96175 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 42.78750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.78750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 19.98725 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 42.78750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.78750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 59.96175 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 39.97450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, SER 155 TO ARG REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 275 REMARK 465 GLY A 276 REMARK 465 TRP A 277 REMARK 465 SER A 278 REMARK 465 VAL A 279 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 GLU A 302 REMARK 465 GLY A 303 REMARK 465 ARG A 304 REMARK 465 MET A 305 REMARK 465 HIS A 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 VAL A 174 CG1 CG2 REMARK 470 HIS A 176 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 177 CG CD OE1 NE2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 181 CG CD OE1 OE2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 GLN A 231 CG CD OE1 NE2 REMARK 470 ARG A 251 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 255 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 307 CG OD1 OD2 REMARK 470 TYR A 334 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 354 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 171 -72.81 -49.38 REMARK 500 ALA A 172 -5.78 -57.52 REMARK 500 HIS A 176 -70.43 -65.26 REMARK 500 LYS A 224 -73.29 -52.98 REMARK 500 PRO A 372 171.52 -59.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A1391 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W1G RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC REMARK 900 SERINE-THREONINE KINASE REMARK 900 RELATED ID: 2J50 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA REMARK 900 -739358 REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 REMARK 900 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 2W1D RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF REMARK 900 AURORA-A REMARK 900 RELATED ID: 2W1E RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA- REMARK 900 680632 REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN REMARK 900 COMPLEX WITH A 5-AMINOPYRIMIDINYL REMARK 900 QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 2J4Z RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA REMARK 900 -680626 REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, REMARK 900 PHOSPHORYLATED ON THR287, THR288 AND BOUND REMARK 900 TO TPX2 1-43 REMARK 900 RELATED ID: 2W1F RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN REMARK 900 COMPLEX WITH ADPNP REMARK 900 RELATED ID: 2W1C RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE DBREF 2WQE A 127 388 UNP O14965 STK6_HUMAN 127 388 SEQADV 2WQE ARG A 155 UNP O14965 SER 155 ENGINEERED MUTATION SEQRES 1 A 262 GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY ARG PRO LEU SEQRES 2 A 262 GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU ALA ARG GLU SEQRES 3 A 262 LYS GLN ARG LYS PHE ILE LEU ALA LEU LYS VAL LEU PHE SEQRES 4 A 262 LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU HIS GLN LEU SEQRES 5 A 262 ARG ARG GLU VAL GLU ILE GLN SER HIS LEU ARG HIS PRO SEQRES 6 A 262 ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS ASP ALA THR SEQRES 7 A 262 ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO LEU GLY THR SEQRES 8 A 262 VAL TYR ARG GLU LEU GLN LYS LEU SER LYS PHE ASP GLU SEQRES 9 A 262 GLN ARG THR ALA THR TYR ILE THR GLU LEU ALA ASN ALA SEQRES 10 A 262 LEU SER TYR CYS HIS SER LYS ARG VAL ILE HIS ARG ASP SEQRES 11 A 262 ILE LYS PRO GLU ASN LEU LEU LEU GLY SER ALA GLY GLU SEQRES 12 A 262 LEU LYS ILE ALA ASP PHE GLY TRP SER VAL HIS ALA PRO SEQRES 13 A 262 SER SER ARG ARG THR THR LEU CYS GLY THR LEU ASP TYR SEQRES 14 A 262 LEU PRO PRO GLU MET ILE GLU GLY ARG MET HIS ASP GLU SEQRES 15 A 262 LYS VAL ASP LEU TRP SER LEU GLY VAL LEU CYS TYR GLU SEQRES 16 A 262 PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA ASN THR TYR SEQRES 17 A 262 GLN GLU THR TYR LYS ARG ILE SER ARG VAL GLU PHE THR SEQRES 18 A 262 PHE PRO ASP PHE VAL THR GLU GLY ALA ARG ASP LEU ILE SEQRES 19 A 262 SER ARG LEU LEU LYS HIS ASN PRO SER GLN ARG PRO MET SEQRES 20 A 262 LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE THR ALA ASN SEQRES 21 A 262 SER SER HET ADP A1389 27 HET ADP A1390 27 HET ADP A1391 27 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE FORMUL 2 ADP 3(C10 H15 N5 O10 P2) FORMUL 3 HOH *30(H2 O1) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 VAL A 174 HIS A 187 1 14 HELIX 4 4 THR A 217 LEU A 225 1 9 HELIX 5 5 ASP A 229 SER A 249 1 21 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 THR A 292 LEU A 296 5 5 HELIX 8 8 PRO A 297 ILE A 301 5 5 HELIX 9 9 LYS A 309 LEU A 315 1 7 HELIX 10 10 VAL A 317 VAL A 324 1 8 HELIX 11 11 THR A 333 ARG A 343 1 11 HELIX 12 12 ALA A 356 LEU A 364 1 9 HELIX 13 13 ASN A 367 ARG A 371 5 5 HELIX 14 14 MET A 373 GLU A 379 1 7 HELIX 15 15 HIS A 380 SER A 387 1 8 SHEET 1 AA 5 PHE A 133 GLU A 134 0 SHEET 2 AA 5 VAL A 147 GLU A 152 -1 O ARG A 151 N GLU A 134 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 PHE A 200 HIS A 201 -1 O PHE A 200 N TYR A 207 SHEET 1 AB 2 LEU A 262 LEU A 263 0 SHEET 2 AB 2 LYS A 271 ILE A 272 -1 O LYS A 271 N LEU A 263 SITE 1 AC1 14 LEU A 139 GLY A 140 LYS A 141 GLY A 142 SITE 2 AC1 14 LYS A 143 VAL A 147 ALA A 160 LYS A 162 SITE 3 AC1 14 LEU A 194 GLU A 211 ALA A 213 THR A 217 SITE 4 AC1 14 LEU A 263 HOH A2028 SITE 1 AC2 10 ILE A 158 LYS A 171 TYR A 212 PRO A 214 SITE 2 AC2 10 SER A 266 LYS A 339 ARG A 340 ARG A 343 SITE 3 AC2 10 GLU A 345 HOH A2024 SITE 1 AC3 7 ARG A 155 PHE A 157 ILE A 158 LEU A 159 SITE 2 AC3 7 ARG A 195 TYR A 197 HOH A2030 CRYST1 85.575 85.575 79.949 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011686 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011686 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012508 0.00000 MASTER 354 0 3 15 7 0 9 6 0 0 0 21 END